Abeona Therapeutics Inc vs Axogen Inc — how do they compare? Abeona Therapeutics Inc trades at $7.34 (market cap $421.19M), while Axogen Inc trades at $48.5 (market cap $2.61B). The key difference: Axogen Inc is far larger — about 6.2× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | AXGN | |
|---|---|---|
Market Cap | $421.19M | $2.61B |
Sector | Health | Technology |
52-Week High | $7.45 | $48.48 |
52-Week Low | $4.17 | $14.16 |
Enterprise Value | $276.10M | $2.52B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →